Although chemerin correlates with necroinflammatory activity and fibrosis in non-alcoholic fatty liver disease (NAFLD) and in viral hepatitis it remains controversial whether chemerin contributes to the pathogenesis of liver disease16–18. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.